Table 6 Oncologic outcomes of non-radical fertility sparing procedures (where N > 10 reported)
Study | N eligible | Surgical procedure (includes pelvic LN assessment) | Successful fertility sparing surgery | N recurrences (mos) | N dead of disease (mos) | Median follow up months for entire series (range) |
|---|---|---|---|---|---|---|
Bisseling 2007 [122] | 18 | 18 cone | 18 | 0 | 0 | 72a |
Rob 2007 [123] | 26 | 15 ST 7 cone | 20 | 1 (14) | 0 | 49 (18–84) |
Landoni 2007 [124] | 11 | 11 cone | 11 | 0 | 0 | 20 (7–29) |
Fagotti 2011 [125] | 17 | 17 cone | 13 | 0 | 0 | 16 (8–101) |
Maneo 2011 [126] | 36 | 36 cone | 31 | 3 (20, 34, 36) | 1 (72) | 66 (18–168) |
Raju 2012 [127] | 15 | 15 ST | 15 | 0 | 0 | 96 (12–120) |
Palaia 2012 [128] | 14 | 14 ST | 14 | 0 | 0 | 38 (18–96) |
Plante 2013 [129] | 16 | 16 ST | 16 | 0 | 0 | 27 (1–65) |
Andikyan 2014 [130] | 10 | 9 cone 1 cx bx | 9 | 0 | 0 | 17 (1–83) |
Bouchard-Fortier 2014 [55] | 29 | 29 cone | 29 | 0 | 0 | 21 (1–112) |
Salihi 2015 [131] | 11 | 11 cone | 9 | 1 (40) | 0 | 58 (13–122) |
Total | 203 | 138 Cone 60 ST | 185 | N = 5 | N = 1 |  |
Crude rates (%) |  |  |  | Recurrence rate = 2.7 %# | Mortality rate = 0.5 %# |  |